alendronate has been researched along with prednisone in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 13 (52.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cappiello, V; Cepollaro, C; Gennari, C; Gonnelli, S; Pondrelli, C; Rottoli, P; Vagliasindi, M | 1 |
| Brown, JP; Czachur, M; Daifotis, AG; Delmas, PD; Emkey, R; Goemaere, S; Hawkins, F; Liberman, UA; Malice, MP; Saag, KG; Schnitzer, TJ; Thamsborg, G | 1 |
| Fallon, JJ; Goldstein, MF; Harning, R | 1 |
| Chidambaran, P; Ettinger, B; Pressman, A | 1 |
| Bertin, P; Inaoui, R; Jaccard, A; Petit, B; Trèves, R | 1 |
| Czachur, M; Daifotis, AG; Delmas, PD; Emkey, R; Goemaere, S; Liberman, UA; Lombardi, A; Poubelle, PE; Verbruggen, N | 1 |
| Jeffery, JR; Karpinski, ME; Leslie, WD; Nickerson, PW; Rush, DN | 1 |
| Chun, CS | 1 |
| Dejardin, A; Devogelaer, JP; Goffin, E | 1 |
| Cundy, T; Hailwood, S; Horne, A; Lucas, J; Rudge, S; Wu, F | 1 |
| Ambler, GR; Chaitow, J; McDonald, DW; Ouvrier, RA; Rogers, M | 1 |
| Bijlsma, JW; Dijkmans, BA; Geusens, P; Lems, WF; Lips, P; Lodder, MC; Schrameijer, N; van de Ven, CM | 1 |
| Papierska, L; Rabijewski, M | 1 |
| Di Comite, G; Rossi, CM | 1 |
| Li, Q; Shi, C; Zou, X | 1 |
| Crozier, J; Massasso, D; Sharma, P; Tsai, TY | 1 |
| Aneiros-Cachaza, J; Aneiros-Fernandez, J; Arias-Santiago, S; Husein-Elahmed, H; Naranjo-Sintes, R | 1 |
| Fett, N; Liu, RH | 1 |
| Koubar, S; Mahmood, K; Ninan, NA; Shofer, SL; Wahidi, MM | 1 |
| Blaeser, A; Bollinger, LE; Cox, MD; Harper, AD; Lu, P; Lu, QL; Luckie, TM; Madden, KL; Richardson, SM; Shah, SN; Sparks, S; Sun, Y; Wu, B | 1 |
| Agnusdei, D; Alam, J; Hans, D; Kohlmeier, LA; Krohn, KD; Leib, ES; MacLaughlin, EJ; Marcus, R; Saag, KG; Simonelli, C; Taylor, KA | 1 |
| Goh, TL; Kendrick-Jones, J | 1 |
| Biver, E; Caruso, A; Fayolle, D; Lefeuvre, L | 1 |
5 review(s) available for alendronate and prednisone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease.
Topics: Administration, Inhalation; Administration, Oral; Adult; Alendronate; Asthma; Bone Density; Bone Remodeling; Calcitonin; Clodronic Acid; Etidronic Acid; Fluorides; Glucocorticoids; Hormone Replacement Therapy; Humans; Lung Diseases, Obstructive; Osteoporosis; Prednisone; Time Factors | 1999 |
Chronic recurrent multifocal osteomyelitis of the spine and mandible: case report and review of the literature.
Topics: Alendronate; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Child, Preschool; Chronic Disease; Female; Humans; Interferon-gamma; Lumbar Vertebrae; Magnetic Resonance Imaging; Mandibular Diseases; Osteomyelitis; Pain; Prednisone; Recurrence; Spinal Diseases | 2004 |
[Glucocorticoid-induced osteoporosis].
Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Calcium; Diphosphonates; Female; Fractures, Spontaneous; Glucocorticoids; Humans; Male; Osteomalacia; Osteoporosis; Parathyroid Hormone; Prednisone; Selective Estrogen Receptor Modulators; Spinal Fractures; Vitamin D | 2007 |
Multicentric reticulohistiocytosis with dermatomyositis-like features: a more common disease presentation than previously thought.
Topics: Alendronate; Antineoplastic Protocols; Arthritis; Breast Neoplasms; Combined Modality Therapy; Dermatologic Agents; Dermatomyositis; Diagnosis, Differential; Drug Therapy, Combination; Female; Histiocytosis; Humans; Lymphatic Metastasis; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone | 2011 |
8 trial(s) available for alendronate and prednisone
| Article | Year |
|---|---|
Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients.
Topics: Absorptiometry, Photon; Adult; Aged; Alendronate; Analysis of Variance; Anti-Inflammatory Agents; Biomarkers; Bone Density; Female; Humans; Male; Middle Aged; Osteoporosis; Prednisone; Sarcoidosis; Thoracic Diseases | 1997 |
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.
Topics: Adolescent; Aged; Aged, 80 and over; Alendronate; Bone Density; Double-Blind Method; Female; Glucocorticoids; Humans; Male; Middle Aged; Osteoporosis; Prednisone; Risk Factors; Spinal Fractures | 1998 |
Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients: a retrospective, observational study.
Topics: Adult; Aged; Alendronate; Bone Density; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Glucocorticoids; Hip; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis; Prednisone; Radiography; Retrospective Studies; Treatment Outcome | 2003 |
Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate.
Topics: Adult; Alendronate; Azathioprine; Bone Density; Bone Resorption; Calcitriol; Calcium Channel Agonists; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone | 2003 |
Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.
Topics: Administration, Oral; Adolescent; Alendronate; Arthritis, Juvenile; Body Height; Bone Density; Bone Resorption; Child; Child, Preschool; Collagen; Collagen Type I; Dermatomyositis; Double-Blind Method; Drug Administration Schedule; Female; Femur; Glucocorticoids; Humans; Lumbar Vertebrae; Lupus Erythematosus, Systemic; Male; Peptides; Prednisone; Stress, Mechanical | 2005 |
Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
Topics: Absorptiometry, Photon; Alendronate; Alkaline Phosphatase; Analysis of Variance; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Collagen Type I; Double-Blind Method; Female; Glucocorticoids; Hip; Humans; Lumbar Vertebrae; Male; Middle Aged; Peptides; Prednisone | 2006 |
[Effect of alendronate on glucocorticoid-induced osteoporosis].
Topics: Adult; Alendronate; Bone Density; Bone Density Conservation Agents; Female; Humans; Male; Middle Aged; Osteoporosis; Prednisone; Rheumatic Fever | 2009 |
Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or Teriparatide.
Topics: Alendronate; Bone Density Conservation Agents; Cancellous Bone; Chronic Disease; Double-Blind Method; Female; Glucocorticoids; Humans; Male; Middle Aged; Osteoporosis; Prednisone; Teriparatide | 2016 |
12 other study(ies) available for alendronate and prednisone
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs.
Topics: Adult; Aged; Alendronate; Calcitonin; California; Drug Prescriptions; Drug Utilization Review; Etidronic Acid; Female; Glucocorticoids; Humans; Male; Middle Aged; Osteoporosis; Prednisone | 2001 |
Aggressive systemic mastocytosis.
Topics: Aged; Alendronate; Bone Marrow Cells; Fatal Outcome; Female; Humans; Interferon-alpha; Leukemia, Myeloid, Acute; Mast Cells; Mast-Cell Sarcoma; Mastocytosis, Systemic; Neoplasms, Multiple Primary; Osteoporosis, Postmenopausal; Prednisone; Serine Endopeptidases; Tryptases | 2003 |
Alendronate versus calcitriol for prevention of bone loss after cardiac transplantation.
Topics: Alendronate; Bone Density; Bone Resorption; Calcitriol; Creatinine; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Prednisone; Renal Insufficiency; Tacrolimus | 2004 |
Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy.
Topics: Alendronate; Calcinosis; Child; Dermatomyositis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Methotrexate; Prednisone; Radiography; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Glucocorticoids; Humans; Osteoporosis; Prednisone; Teriparatide | 2008 |
Taking PET for a walk - an unusual cause of bilateral leg claudication.
Topics: Alendronate; Anti-Inflammatory Agents; Aspirin; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Intermittent Claudication; Middle Aged; Prednisone; Radionuclide Imaging; Treatment Outcome | 2010 |
Lichenoid dermatosis induced by alendronate: an unusual skin drug reaction.
Topics: Aged; Alendronate; Biopsy; Bone Density Conservation Agents; Glucocorticoids; Humans; Lichenoid Eruptions; Lumbar Vertebrae; Male; Osteoporosis; Prednisone; Skin; Spinal Fractures; Treatment Outcome | 2010 |
Alendronate tracheobronchitis.
Topics: Alendronate; Anti-Bacterial Agents; Anti-Inflammatory Agents; Biopsy; Bone Density Conservation Agents; Bronchitis; Bronchoscopy; Debridement; Female; Humans; Middle Aged; Osteoporosis; Prednisone; Respiratory System; Tracheitis; Treatment Outcome | 2013 |
Glucocorticoid Steroid and Alendronate Treatment Alleviates Dystrophic Phenotype with Enhanced Functional Glycosylation of α-Dystroglycan in Mouse Model of Limb-Girdle Muscular Dystrophy with FKRPP448L Mutation.
Topics: Adrenal Cortex Hormones; Alendronate; Animals; Blotting, Western; Bone Density; Bone Density Conservation Agents; Dystroglycans; Glycosylation; Mice; Mice, Mutant Strains; Muscle, Skeletal; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophy, Animal; Phenotype; Prednisone | 2016 |
Alendronate sodium-induced interstitial nephritis.
Topics: Alendronate; Bone Density Conservation Agents; Creatinine; Female; Humans; Middle Aged; Nephritis, Interstitial; Prednisone | 2017 |
Orbital myositis induced by alendronate: A case report.
Topics: Aged; Alendronate; Diphosphonates; Female; Humans; Orbital Myositis; Osteoporosis; Prednisone | 2023 |